Targeting drug delivery system for platinum(Ⅳ)-Based antitumor complexes

顺铂 铂金 化学 前药 药理学 生物利用度 药物输送 药品 体内 组合化学 化疗 医学 生物化学 内科学 生物 有机化学 催化作用 生物技术
作者
Yunshuang Zhong,Chunyan Jia,Xinzhong Zhang,Xiali Liao,Bo Yang,Yan-Wei Cong,Shao-Ping Pu,Chuanzhu Gao
出处
期刊:European journal of medicinal chemistry [Elsevier]
卷期号:194: 112229-112229 被引量:53
标识
DOI:10.1016/j.ejmech.2020.112229
摘要

Classical platinum(II) anticancer agents are widely-used chemotherapeutic drugs in the clinic against a range of cancers. However, severe systemic toxicity and drug resistance have become the main obstacles which limit their application and effectiveness. Because divalent cisplatin analogues are easily destroyed in vivo, their bioavailability is low and no selective to tumor tissues. The platinum(IV) prodrugs are attractive compounds for cancer treatment because they have great advantages, e.g., higher stability in biological media, aqueous solubility and no cross-resistance with cisplatin, which may become the next generation of platinum anticancer drugs. In addition, platinum(IV) drugs could be taken orally, which could be more acceptable to cancer patients, breaking the current situation that platinum(II) drugs can only be given by injection. The coupling of platinum(IV) complexes with tumor targeting groups avoids the disadvantages such as instability in blood, irreversible binding to plasma proteins, rapid renal clearance, and non-specific distribution in normal tissues. Because of the above advantages, the combination of platinum complexes and tumor targeting groups has become the hottest field in the research and development of new platinum drugs. These approaches can be roughly categorized into two groups: active and passive targeted strategies. This review concentrates on various targeting and delivery strategies for platinum(IV) complexes to improve the efficacy and reduce the side effects of platinum-based anticancer drugs. We have made a summary of the related articles on platinum(IV) targeted delivery in recent years. We believe the results of the studies described in this review will provide new ideas and strategies for the development of platinum drugs. • Platinum(IV) emerges as promising candidate for overcoming the shortcomings of platinum(II). • Various DTD systems for platinum(IV) is a hotspot of platinum anticancer chemotherapeutic drugs. • This review provides new ideas and strategies for the development of platinum drugs.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
更新
大幅提高文件上传限制,最高150M (2024-4-1)

科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
高兴的灰狼完成签到,获得积分10
刚刚
水池完成签到,获得积分10
刚刚
深情安青应助张英俊采纳,获得10
1秒前
1秒前
2秒前
2028847955发布了新的文献求助10
2秒前
SPQR完成签到,获得积分10
3秒前
3秒前
zho应助lyn采纳,获得10
4秒前
4秒前
SciGPT应助栖月采纳,获得10
5秒前
6秒前
斯文的映真完成签到,获得积分10
6秒前
6秒前
Oveja发布了新的文献求助30
7秒前
BB发布了新的文献求助10
7秒前
8秒前
Wy21发布了新的文献求助10
8秒前
8秒前
避橙发布了新的文献求助10
8秒前
9秒前
10秒前
10秒前
11秒前
张英俊完成签到,获得积分10
11秒前
细腻盼烟完成签到,获得积分10
13秒前
张英俊发布了新的文献求助10
13秒前
肚子饿了发布了新的文献求助10
14秒前
FashionBoy应助璇er采纳,获得10
14秒前
慕青应助无端采纳,获得10
15秒前
英姑应助Wy21采纳,获得10
15秒前
kingripple发布了新的文献求助10
15秒前
瘦瘦小萱完成签到,获得积分10
16秒前
王达庆发布了新的文献求助30
17秒前
大个应助科研人采纳,获得10
18秒前
星辰大海应助ECCE采纳,获得10
18秒前
华仔应助张英俊采纳,获得10
18秒前
李爱国应助2028847955采纳,获得10
19秒前
倒脱靴完成签到,获得积分10
19秒前
19秒前
高分求助中
The late Devonian Standard Conodont Zonation 2000
Nickel superalloy market size, share, growth, trends, and forecast 2023-2030 2000
The Lali Section: An Excellent Reference Section for Upper - Devonian in South China 1500
Smart but Scattered: The Revolutionary Executive Skills Approach to Helping Kids Reach Their Potential (第二版) 1000
Very-high-order BVD Schemes Using β-variable THINC Method 830
Mantiden: Faszinierende Lauerjäger Faszinierende Lauerjäger 800
PraxisRatgeber: Mantiden: Faszinierende Lauerjäger 800
热门求助领域 (近24小时)
化学 医学 生物 材料科学 工程类 有机化学 生物化学 物理 内科学 纳米技术 计算机科学 化学工程 复合材料 基因 遗传学 催化作用 物理化学 免疫学 量子力学 细胞生物学
热门帖子
关注 科研通微信公众号,转发送积分 3247867
求助须知:如何正确求助?哪些是违规求助? 2891062
关于积分的说明 8266031
捐赠科研通 2559319
什么是DOI,文献DOI怎么找? 1388095
科研通“疑难数据库(出版商)”最低求助积分说明 650694
邀请新用户注册赠送积分活动 627581